Invention Grant
- Patent Title: 1-heterocyclyl isochromanyl compounds and analogs for treating CNS disorders
-
Application No.: US16403698Application Date: 2019-05-06
-
Publication No.: US11192885B2Publication Date: 2021-12-07
- Inventor: Linghong Xie , Philip Glyn Jones , Kerry L. Spear , Noel Aaron Powell , Taleen G. Hanania , Vadim Alexandrov
- Applicant: Sunovion Pharmaceuticals Inc. , PGI Drug Discovery LLC
- Applicant Address: US MA Marlborough; US NJ Paramus
- Assignee: Sunovion Pharmaceuticals Inc.,PGI Drug Discovery LLC
- Current Assignee: Sunovion Pharmaceuticals Inc.,PGI Drug Discovery LLC
- Current Assignee Address: US MA Marlborough; US NJ Paramus
- Agency: Heslin Rothenberg Farley & Mesiti P.C.
- Main IPC: C07D405/04
- IPC: C07D405/04 ; C07D405/14 ; C07D413/14 ; C07D493/04 ; C07D413/04
Abstract:
Disclosed are compounds of Formula (I): and pharmaceutically acceptable salts thereof, wherein A, Ra, R1, R2, R3, R4, R6, w and n1 are defined and described herein; compositions thereof; and methods of use thereof. These compounds are useful for treating a variety of neurological and psychiatric disorders, such as those described herein.
Public/Granted literature
- US20190389845A1 1-HETEROCYCLYL ISOCHROMANYL COMPOUNDS AND ANALOGS FOR TREATING CNS DISORDERS Public/Granted day:2019-12-26
Information query
